GDTC
CytoMed Therapeutics Ltd.
NASDAQ · Healthcare · Biotechnology · SG
$0.86
−5.49%Margins
Gross margin
-577.7%
EBITDA margin
-671.3%
EBIT margin
-794.6%
Net margin
-730.3%
FCF margin
-874.9%
-105.9%
Return on equity
-75.1%
Return on assets
-105.6%
Return on invested capital
0.10x
Asset turnover
-$4.4M
Cash from operations
$0.10
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026